This site is intended for Healthcare Professionals only.

Tag: AstraZeneca

spot_imgspot_img

UK’s C4X Discovery signs $400m deal with AstraZeneca to develop treatment of respiratory diseases

British drug discovery company C4X Discovery said AstraZeneca had signed a licence worth up $402 million to develop an oral therapy for the treatment of inflammatory...

India gets ready to start administering Covid mix-and-match booster vaccines

Health authorities in India have said that Biological E's Covid-19 vaccine Corbevax can be administered as a booster dose in people who have taken...

AstraZeneca profits fall due to rising cost following takeover of US biotech firm Alexion

Covid-vaccine maker AstraZeneca said Friday that profits fell sharply in the first half on ballooning costs linked to its takeover of US biotech firm...

AstraZeneca’s Evusheld gets MHRA approval to treat Covid-19 patients

A new medicine, Evusheld (tixagevimab/cilgavimab), has been authorised for Covid-19 prevention after meeting the UK regulatory standards of safety, quality and effectiveness. The Medicines...

AstraZeneca inks pact with Scorpion Therapeutics to develop medicines against cancer proteins

Global pharmaceutical and biotechnology company AstraZeneca has signed an agreement with Scorpion Therapeutics to discover, develop and commercialize precision medicines against cancer proteins. The collaboration,...

UK marks first anniversary of Oxford-AstraZeneca vaccine

Health services in the UK today (January 4) marked the first anniversary of the deployment of the Oxford University/AstraZeneca vaccine in fight against Covid-19. Exactly...